Plexus (NASDAQ:PLXS – Get Free Report) was downgraded by stock analysts at Sidoti from a “buy” rating to a “neutral” rating in a research note issued to investors on Friday, MarketBeat reports. They currently have a $150.00 target price on the technology company’s stock. Sidoti’s price objective points to a potential upside of 4.22% from the company’s current price.
A number of other research analysts also recently commented on PLXS. Needham & Company LLC increased their price target on shares of Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a report on Thursday. Williams Trading set a $165.00 price target on shares of Plexus in a report on Monday, September 22nd. Stifel Nicolaus set a $140.00 price target on shares of Plexus in a report on Thursday, July 24th. Wall Street Zen downgraded shares of Plexus from a “strong-buy” rating to a “buy” rating in a report on Sunday, October 19th. Finally, Benchmark reaffirmed a “buy” rating and issued a $165.00 price target on shares of Plexus in a report on Friday. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $159.00.
Read Our Latest Research Report on Plexus
Plexus Stock Down 4.0%
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, October 22nd. The technology company reported $2.14 EPS for the quarter, beating the consensus estimate of $1.84 by $0.30. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The business had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the firm earned $1.85 EPS. The business’s revenue was up .7% on a year-over-year basis. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. Analysts forecast that Plexus will post 5.9 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, COO Oliver K. Mihm sold 2,102 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $130.43, for a total value of $274,163.86. Following the sale, the chief operating officer directly owned 21,155 shares of the company’s stock, valued at $2,759,246.65. This represents a 9.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of the stock in a transaction dated Thursday, August 28th. The stock was sold at an average price of $139.00, for a total transaction of $417,000.00. Following the completion of the sale, the insider directly owned 8,723 shares in the company, valued at $1,212,497. This trade represents a 25.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,856 shares of company stock worth $2,142,440 over the last three months. 1.76% of the stock is currently owned by company insiders.
Institutional Trading of Plexus
Several institutional investors and hedge funds have recently modified their holdings of PLXS. Congress Asset Management Co. lifted its holdings in shares of Plexus by 0.5% in the 3rd quarter. Congress Asset Management Co. now owns 16,245 shares of the technology company’s stock worth $2,350,000 after buying an additional 88 shares during the period. Huntington National Bank lifted its holdings in shares of Plexus by 41.5% in the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after buying an additional 95 shares during the period. Nisa Investment Advisors LLC lifted its holdings in shares of Plexus by 0.8% in the 3rd quarter. Nisa Investment Advisors LLC now owns 12,879 shares of the technology company’s stock worth $1,863,000 after buying an additional 99 shares during the period. Xponance Inc. lifted its holdings in shares of Plexus by 4.8% in the 1st quarter. Xponance Inc. now owns 2,315 shares of the technology company’s stock worth $297,000 after buying an additional 106 shares during the period. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Plexus by 7.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,750 shares of the technology company’s stock worth $237,000 after buying an additional 116 shares during the period. Institutional investors own 94.45% of the company’s stock.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories
- Five stocks we like better than Plexus
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- How to Read Stock Charts for Beginners
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- Growth Stocks: What They Are, Examples and How to Invest
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
